Research test kit RUO

COVID-19SARS-COV-2clinical

The global COVID-19 pandemic created an unprecedented need to quickly deploy emergency tests for SARS-CoV-2 infection. Now, scientists can harness the flexibility and reproducibility of LC-MS to advance critical SARS-CoV-2 research. Waters SARS-CoV-2 LC-MS Kit (RUO) is a Research Use Only kit to directly detect and quantify SARS-CoV-2 signature nucleocapsid peptides (NCAPs) without the need to amplify the target analytes – so you can ensure accuracy, reproducibility, and sensitivity for your most critical research. Overview Achieve reproducible results between and within labs  Ensure high accuracy and analytical sensitivity to enable critical research  Empower research and development of pioneering SARS-CoV-2 testing with an alternative and complementary technology to common infectious pathogen research  Enable broader research with an LC-MS method with the potential to be multiplexed with other peptides and biomarkers * This kit is for research use only and has not been approved for use in clinical diagnostic procedures. This RUO kit has not been tested with clinical samples. The SARS-CoV-2 kit for SARS-CoV-2 nucleocapsid peptides is not available in all countries, please contact your Waters representative for more details. The Waters SARS-CoV-2 LC-MS Kit (RUO) is a Research Use Only kit intended for the quantitative measurement of three proteolytic peptides derived from the SARS-CoV-2 Nucleocapsid (NCAP) protein.The method has been optimized on an ACQUITY UPLC I-Class PLUS and Xevo TQ-XS System and is also intended for use with the Andrew+ Pipetting Robot. Optimization on other instrument platforms is possible.